Provider 1487191573
Total Paid
$8.9M
$8,873,963
Total Claims
319K
Beneficiaries
119K
2.7 claims/patient
Avg Cost/Claim
$28
Monthly Spending Trend
Yearly Spending
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 30 distinct procedure codes. The top code (U0003 (Infectious disease detection (COVID-19))) accounts for 55% of total spending.
$4.9M
64K claims
$75.76
$63.08
Infectious disease detection (COVID-19)
$4.9M
64K claims · 54.8%
$1.0M
17K claims
$61.18
$60.05
COVID-19 test, nucleic acid detection, CDC lab only
$1.0M
17K claims · 11.8%
$591K
43K claims
$13.62
$35.43
Drug test, presumptive, by chemistry analyzers
$591K
43K claims · 6.7%
$381K
9,495 claims
$40.11
$75.26
Drug test, definitive, 15-21 drug classes
$381K
9,495 claims · 4.3%
$347K
8,555 claims
$40.57
$37.56
Drug test, definitive, 1-7 drug classes
$347K
8,555 claims · 3.9%
$259K
17K claims
$15.71
$17.15
Specimen collection for COVID-19 testing
$259K
17K claims · 2.9%
$239K
9,207 claims
$25.94
$90.89
Drug test, definitive, 22+ drug classes
$239K
9,207 claims · 2.7%
$94K
9,425 claims
$9.99
$15.76
Infectious disease detection, COVID-19, antigen
$94K
9,425 claims · 1.1%
$60K
1,972 claims
$30.61
$30.04
SARS-CoV-2 COVID-19 antigen detection, immunoassay
$60K
1,972 claims · 0.7%
$38K
4,238 claims · 0.4%
$37K
3,732 claims · 0.4%
$37K
4,294 claims · 0.4%
$37K
4,291 claims · 0.4%
$35K
3,470 claims · 0.4%
$35K
3,532 claims · 0.4%
$34K
3,477 claims · 0.4%
$34K
4,423 claims · 0.4%
$33K
4,420 claims
$7.58
$5.78
Benzodiazepine drug assay by definitive method
$33K
4,420 claims · 0.4%
$33K
4,227 claims · 0.4%
$33K
3,865 claims · 0.4%
$33K
3,791 claims · 0.4%
$33K
3,794 claims · 0.4%
$33K
3,795 claims · 0.4%
$33K
3,769 claims · 0.4%
Drug assay for barbiturates
$33K
3,769 claims · 0.4%
$33K
3,878 claims · 0.4%
$33K
6,443 claims · 0.4%
$33K
3,741 claims · 0.4%
$33K
3,769 claims · 0.4%
$33K
3,808 claims
$8.63
$5.26
Benzodiazepine drug level, definitive method, each
$33K
3,808 claims · 0.4%